Home


  Fiscal Year Ended
  Shares       Dollars    
   
 
In millions January 1,
2000
  December 26,
1998
    December 27,
1997
  January 1,
2000
  December 26,
1998
    December 27,
1997

Preference stock:          
  Beginning of year 5.2 5.3 5.6 $280.0 $284.6 $298.6
  Conversion to common stock (0.1) (0.3) (4.0) (4.6) (14.0)

  End of year 5.2 5.2 5.3 276.0 280.0 284.6

Common stock:          
  Beginning of year 401.4 393.7 369.3 4.0 3.9 3.7
  Stock options exercised and awards under stock plans 1.0 7.5 10.9 0.1 0.1
  Other 0.6 0.2 13.5 0.1

  End of year 403.0 401.4 393.7 4.0 4.0 3.9

Treasury stock:          
  Beginning of year (11.2) (11.3) (11.7) (260.2) (262.9) (273.1)
  Conversion of preference stock 0.2 0.2 0.5 4.0 4.2 12.2
  Other (0.1) (0.1) (0.1) (2.3) (1.5) (2.0)

  End of year (11.1) (11.2) (11.3) (258.5) (260.2) (262.9)

Guaranteed ESOP obligation:
  Beginning of year (270.7) (292.2) (292.2)
  Reduction of guaranteed ESOP obligation 13.7 21.5

  End of year (257.0) (270.7) (292.2)

Capital surplus:
  Beginning of year 1,336.4 1,154.0 941.2
  Conversion of preference stock 0.1 0.3 1.8
  Stock options exercised and awards under stock plans 31.3 176.2 195.9
  Other 3.9 5.9 15.1

  End of year 1,371.7 1,336.4 1,154.0

Retained earnings:
  Beginning of year 2,021.1 1,739.1 1,737.9
  Net earnings 635.1 384.5 88.8
  Dividends:
      Preference stock, net of income tax benefit (14.7) (13.6) (13.7)
      Common stock (90.0) (88.9) (73.9)
  Immaterial pooling of interests 8.0

  End of year 2,543.5 2,021.1 1,739.1

Other:
  Beginning of year (2.4)
  Unrealized holding gain on investments, net 2.4

  End of year

Total shareholders’ equity $3,679.7 $3,110.6 $2,626.5

See accompanying notes to consolidated financial statements.

Download this section in PDF format.

home

copyright 1999 CVS/pharmacy, Inc.
For Investor web site questions/comments, send e-mail to investorinfo@cvs.com